AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Europe Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: A 31-Country Analysis Including France, Italy & Spain - ResearchAndMarkets.com

October 11, 2019

DUBLIN--(BUSINESS WIRE)--Oct 11, 2019--

The “Europe Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: A 31-Country Analysis-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities” report has been added to ResearchAndMarkets.com’s offering.

This new 31-country report from the author is available by country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Country Analyses

Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK

Market Segmentation Analysis

Product/Technology Review

Competitive Assessments

Opportunities and Strategic Recommendations

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/fawzgm

View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005253/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 10/11/2019 07:54 AM/DISC: 10/11/2019 07:54 AM

http://www.businesswire.com/news/home/20191011005253/en